Pulmonx Corp (LUNG) stock
Close on Nov 11, 2026Market cap $127.99MP/E –Yield –
Pulmonx Corp saw revenue fall 3.2% to $88.78M over the twelve months to Sep 30, 2026. Free cash flow was -$25.61M. At the latest close the market valued the company at $127.99M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $127.99M
- P/E ratio
- –
- Price to sales
- 1.44
- Price to book
- 3.74
- Dividend yield
- –
- Free cash flow yield
- -20.01%
Fundamentals
- Revenue
- $88.78M
- Net income
- -$42.55M
- EPS, diluted
- -$1.01
- Free cash flow
- -$25.61M
- Book value per share
- $0.79
- Diluted shares
- 43M
Trading
- Next earnings
- Mar 3, 2027 (estimated, during market hours)
- Previous close
- $2.80
- Open
- $2.80
- Day's range
- $2.71 – $2.98
- Volume
- 905,532
- Average volume (20 days)
- 1,245,748
- Beta (5 years)
- 1.74
- 52-week range
- $1.13 – $3.25
- RSI (14 days)
- 65.9
- Volatility (1 year)
- 98.8%
- Relative volume
- 1.44×
- WACC
- 12.5%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | LUNG | S&P 500 | Difference | LUNG per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +62.0% | -2.4% | +64.4 pts | ||
| 3 months | +31.9% | -1.2% | +33.0 pts | ||
| Year to date | +34.8% | +12.3% | +22.5 pts | ||
| 1 year | +42.6% | +12.4% | +30.1 pts | ||
| 3 years | -67.8% | +78.8% | −146.6 pts | -31.4% | +21.4% |
| 5 years | -92.9% | +75.2% | −168.0 pts | -41.0% | +11.9% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Pulmonx filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Pulmonx
Surgical & Medical Instruments & Apparatus
The company is a commercial-stage medical technology business that develops and provides minimally invasive treatments for patients suffering from severe emphysema, a form of chronic obstructive pulmonary disease. Its core solution combines the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System, and the LungTraX cloud-based analysis platform. In addition, the business manufactures the AeriSeal System, an investigational synthetic polymer foam designed to close collateral air channels in targeted lung lobes. The enterprise primarily sells its products directly to hospital customers, while focusing its sales and educational initiatives on interventional pulmonologists performing pulmonary procedures.
Company profile, executives and historyPulmonx stock: common questions
What is Pulmonx's stock price?
LUNG closed at $2.98 on Nov 11, 2026, up 6.43% on the day. Over the past 52 weeks it traded between $1.13 and $3.25.
What is Pulmonx's market cap?
Pulmonx was worth $127.99M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is LUNG's P/E ratio?
Pulmonx lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.01), so it has no meaningful P/E ratio.
How much revenue does Pulmonx make?
Pulmonx reported revenue of $88.78M for the twelve months to Sep 30, 2026, down 3.2% from a year earlier.
Does Pulmonx pay a dividend?
No. Pulmonx has not paid a cash dividend over the last twelve months.
When does Pulmonx report earnings next?
Pulmonx is expected to report Q4 FY2026 results on Mar 3, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has LUNG stock performed over the past year?
Including dividends, LUNG returned +42.6% over the past year, against +12.4% for the S&P 500.
How many LUNG shares are sold short?
1M shares were sold short at the latest FINRA report, 2.20% of the float, or 1.0 days of average trading volume.
Who are Pulmonx's competitors?
Companies most similar to Pulmonx by business, industry and size include TELA, CVRX, IRMD, SGHT, APYX.
See a number that looks wrong?